InflaRx intends to engage with EMA regarding both vilobelimab and izicopan to evaluate the regulatory path to approval in ANCA-associated vasculitis (AAV) The Company is assessing the most efficient ...
Two-dimensional (2D) perovskites are increasingly recognized as promising candidate materials for the next generation of ...
We spoke to David Klenerman, co-developer of sequencing by synthesis, to find out how his work heralded the next generation ...
A new study reveals that dual-atom catalysts behave in a fundamentally different way than scientists previously thought, challenging a long-standing model used to predict catalytic performance.
We independently review everything we recommend. When you buy through our links, we may earn a commission. Learn more› By James Austin James Austin is a writer covering games and hobbies, which means ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results